Methods For Treating Obesity And Nonalcoholic Fatty Liver Disease Or Nonalcoholic Steatohepatitis Using Glucagon Receptor Antagonistic Antibodies

• 收藏
• 分享

专利权人:

Inc.;REMD Biotherapeutics

发明人:

Hai Yan,Jim Shi,Jeong Oh

申请号：

US15563162

公开号：

US20180079820A1

申请日:

2016.03.31

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present disclosure relates to methods for treating or preventing obesity and/or nonalcoholic fatty liver diseases (NAFLDs) and/or nonalcoholic steatohepatitis (NASH) using a glucagon receptor blocking agent. In various embodiments, the present disclosure relates to methods for treating or preventing NAFLD/NASH using antigen binding and antagonizing proteins, e.g., fully human antibodies, that specifically bind to and antagonize the function of the human glucagon receptor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/